Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes

Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Raffaello Verardi, Lisa C. Lindesmith, Yaroslav Tsybovsky, Jason Gorman, Gwo-Yu Chuang, Caitlin E. Edwards, Paul D. Brewer-Jensen, Michael L. Mallory, Li Ou, Arne Schön, Wei Shi, Ena S. Tully, George Georgiou, Ralph S. Baric, Peter D. Kwong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/291f486fe191490c902890335db78af5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:291f486fe191490c902890335db78af5
record_format dspace
spelling oai:doaj.org-article:291f486fe191490c902890335db78af52021-12-02T12:42:26ZDisulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes10.1038/s41541-020-00260-w2059-0105https://doaj.org/article/291f486fe191490c902890335db78af52020-12-01T00:00:00Zhttps://doi.org/10.1038/s41541-020-00260-whttps://doaj.org/toc/2059-0105Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited. Here, we show that norovirus GI.1 VLPs are unstable and contain a substantial fraction of dissociated VLP components. Broadly reactive, non-neutralizing antibodies isolated from vaccinated donors bound to the dissociated components, but not to the intact VLPs. Engineering of interprotomer disulfide bonds within the shell domain prevented disassembly of the VLPs, while preserving antibody accessibility to blockade epitopes. Without adjuvant, mice immunized with stabilized GI.1 VLPs developed faster blockade antibody titers compared to immunization with wild-type GI.1 VLPs. In addition, immunization with stabilized particles focused immune responses toward surface-exposed epitopes and away from occluded epitopes. Overall, disulfide-stabilized norovirus GI.1 VLPs elicited improved responses over the non-disulfide-stabilized version, suggesting their promise as candidate vaccines.Raffaello VerardiLisa C. LindesmithYaroslav TsybovskyJason GormanGwo-Yu ChuangCaitlin E. EdwardsPaul D. Brewer-JensenMichael L. MalloryLi OuArne SchönWei ShiEna S. TullyGeorge GeorgiouRalph S. BaricPeter D. KwongNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 5, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Raffaello Verardi
Lisa C. Lindesmith
Yaroslav Tsybovsky
Jason Gorman
Gwo-Yu Chuang
Caitlin E. Edwards
Paul D. Brewer-Jensen
Michael L. Mallory
Li Ou
Arne Schön
Wei Shi
Ena S. Tully
George Georgiou
Ralph S. Baric
Peter D. Kwong
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
description Abstract Human noroviruses are non-enveloped, single-strand RNA viruses that cause pandemic outbreaks of acute gastroenteritis. A bivalent vaccine containing GI.1 and GII.4 virus-like particles (VLPs) has been shown to be safe and highly immunogenic, but its efficacy and durability have been limited. Here, we show that norovirus GI.1 VLPs are unstable and contain a substantial fraction of dissociated VLP components. Broadly reactive, non-neutralizing antibodies isolated from vaccinated donors bound to the dissociated components, but not to the intact VLPs. Engineering of interprotomer disulfide bonds within the shell domain prevented disassembly of the VLPs, while preserving antibody accessibility to blockade epitopes. Without adjuvant, mice immunized with stabilized GI.1 VLPs developed faster blockade antibody titers compared to immunization with wild-type GI.1 VLPs. In addition, immunization with stabilized particles focused immune responses toward surface-exposed epitopes and away from occluded epitopes. Overall, disulfide-stabilized norovirus GI.1 VLPs elicited improved responses over the non-disulfide-stabilized version, suggesting their promise as candidate vaccines.
format article
author Raffaello Verardi
Lisa C. Lindesmith
Yaroslav Tsybovsky
Jason Gorman
Gwo-Yu Chuang
Caitlin E. Edwards
Paul D. Brewer-Jensen
Michael L. Mallory
Li Ou
Arne Schön
Wei Shi
Ena S. Tully
George Georgiou
Ralph S. Baric
Peter D. Kwong
author_facet Raffaello Verardi
Lisa C. Lindesmith
Yaroslav Tsybovsky
Jason Gorman
Gwo-Yu Chuang
Caitlin E. Edwards
Paul D. Brewer-Jensen
Michael L. Mallory
Li Ou
Arne Schön
Wei Shi
Ena S. Tully
George Georgiou
Ralph S. Baric
Peter D. Kwong
author_sort Raffaello Verardi
title Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
title_short Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
title_full Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
title_fullStr Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
title_full_unstemmed Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
title_sort disulfide stabilization of human norovirus gi.1 virus-like particles focuses immune response toward blockade epitopes
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/291f486fe191490c902890335db78af5
work_keys_str_mv AT raffaelloverardi disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT lisaclindesmith disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT yaroslavtsybovsky disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT jasongorman disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT gwoyuchuang disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT caitlineedwards disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT pauldbrewerjensen disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT michaellmallory disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT liou disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT arneschon disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT weishi disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT enastully disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT georgegeorgiou disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT ralphsbaric disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
AT peterdkwong disulfidestabilizationofhumannorovirusgi1viruslikeparticlesfocusesimmuneresponsetowardblockadeepitopes
_version_ 1718393673574514688